How many stocks are there of Virbac?
The current number of stocks of Virbac is 8.44 M undefined.
Virbac Stocks 2024
Virbac Stocks
8.44 M
Ticker
VIRP.PA
ISIN
FR0000031577
WKN
874929
In 2024, Virbac had 8.44 M outstanding stocks, a 0% change from the 8.44 M stocks in the previous year.
The Virbac Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2028e | 8.44 |
| 2027e | 8.44 |
| 2026e | 8.44 |
| 2025e | 8.44 |
| 2024e | 8.44 |
| 2023 | 8.44 |
| 2022 | 8.45 |
| 2021 | 8.45 |
| 2020 | 8.44 |
| 2019 | 8.43 |
| 2018 | 8.42 |
| 2017 | 8.42 |
| 2016 | 8.43 |
| 2015 | 8.43 |
| 2014 | 8.43 |
| 2013 | 8.43 |
| 2012 | 8.42 |
| 2011 | 8.42 |
| 2010 | 8.67 |
| 2009 | 8.67 |
| 2008 | 8.61 |
| 2007 | 8.61 |
| 2006 | 8.55 |
| 2005 | 8.48 |
| 2004 | 8.31 |
Virbac shares outstanding FR0000031577 · 874929
The number of shares was Virbac in 2023 — This indicates how many shares 8.437 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Virbac earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Virbac's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Virbac’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Virbac's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 8.31 M Aktien |
| 2005 | 8.48 M Aktien |
| 2006 | 8.55 M Aktien |
| 2007 | 8.61 M Aktien |
| 2008 | 8.61 M Aktien |
| 2009 | 8.67 M Aktien |
| 2010 | 8.67 M Aktien |
| 2011 | 8.42 M Aktien |
| 2012 | 8.42 M Aktien |
| 2013 | 8.43 M Aktien |
| 2014 | 8.43 M Aktien |
| 2015 | 8.43 M Aktien |
| 2016 | 8.43 M Aktien |
| 2017 | 8.42 M Aktien |
| 2018 | 8.42 M Aktien |
| 2019 | 8.43 M Aktien |
| 2020 | 8.44 M Aktien |
| 2021 | 8.45 M Aktien |
| 2022 | 8.45 M Aktien |
| 2023 | 8.44 M Aktien |
| 2024e | 8.44 M Aktien |
| 2025e | 8.44 M Aktien |
| 2026e | 8.44 M Aktien |
| 2027e | 8.44 M Aktien |
| 2028e | 8.44 M Aktien |
Virbac Aktienanalyse
What does Virbac do?
Virbac SA is a French company specializing in animal medicines and care products. The company was founded in 1968 by Pierre Richard Dick, who studied veterinary medicine at the École nationale vétérinaire d'Alfort and gained experience as a veterinarian. Since its founding, Virbac SA has been headquartered near Carros, France and operates worldwide. The business model of Virbac SA is to offer a wide range of products to veterinarians and pet owners, aiming to ensure optimal health, care, and quality of life for their pets. This includes everything from vaccines, diagnostics, and medications to grooming products that veterinarians and pet owners need to ensure optimal pet healthcare. Virbac SA has five main business areas, namely livestock, pets, horses, hygiene products, and specialties. The livestock sector includes products such as feed additives and antiparasitics tailored to the specific needs of cattle, pigs, poultry, and fish. In the pets sector, Virbac SA offers products specifically tailored to dogs, cats, birds, and other pets. This includes both disease prevention and treatment products. In the horse sector, the company offers products for the maintenance, care, and health of horses. Another division of Virbac SA is hygiene products. The company offers a wide portfolio of products and solutions that support both veterinarians and pet owners in ensuring the health and care of animals. This ranges from infection control products to animal-specific shampoos and grooming items. The specialties sector, on the other hand, includes specialized products such as targeted diagnostics, therapeutics, and dietary supplements. The constant focus on research and development also leads to innovative product launches that consistently meet the highest quality standards. An example of this is the scientifically developed dental hygiene product line that improves both the oral health and breath quality of dogs and cats. For this, Virbac SA also receives awards from the Veterinary Center for Clinical Medicine in Munich. Through a systematic international expansion strategy, Virbac SA is now present in more than 100 countries. The company employs over 4,800 people worldwide and achieved a turnover of 954 million euros in 2019. Overall, Virbac SA stands for consistently high product quality and a strong customer orientation. With a combination of expertise and extensive scientific research and development, particularly in the field of animal health and care, the company is an important player in the global animal medicine manufacturing market. Virbac ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Virbac's Shares Outstanding
Virbac's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Virbac’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Virbac’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Virbac’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Virbac stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Virbac are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Virbac evolved in recent years?
The number of shares of Virbac has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Virbac as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Virbac?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Virbac pay?
Over the past 12 months, Virbac paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Virbac is expected to pay a dividend of 1.5 EUR.
What is the dividend yield of Virbac?
The current dividend yield of Virbac is .
When does Virbac pay dividends?
Virbac pays a quarterly dividend. This is distributed in the months of July, July, July, July.
How secure is the dividend of Virbac?
Virbac paid dividends every year for the past 8 years.
What is the dividend of Virbac?
For the upcoming 12 months, dividends amounting to 1.5 EUR are expected. This corresponds to a dividend yield of 0.46 %.
In which sector is Virbac located?
Virbac is assigned to the 'Health' sector.
Wann musste ich die Aktien von Virbac kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Virbac from 6/27/2024 amounting to 1.32 EUR, you needed to have the stock in your portfolio before the ex-date on 6/25/2024.
When did Virbac pay the last dividend?
The last dividend was paid out on 6/27/2024.
What was the dividend of Virbac in the year 2023?
In the year 2023, Virbac distributed 1.25 EUR as dividends.
In which currency does Virbac pay out the dividend?
The dividends of Virbac are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Virbac stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Virbac
Our stock analysis for Virbac Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Virbac Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
